Mario Cazzola
Mario Cazzola
Professor of Hematology, University of Pavia
Verified email at unipv.it
Title
Cited by
Cited by
Year
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
DA Arber, A Orazi, R Hasserjian, J Thiele, MJ Borowitz, MM Le Beau, ...
Blood 127 (20), 2391-2405, 2016
40452016
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics, F Passamonti, AS Buser, SS Teo, R Tiedt, JR Passweg, ...
New England Journal of Medicine 352 (17), 1779-1790, 2005
36992005
Revised international prognostic scoring system for myelodysplastic syndromes
PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F SolÚ, ...
Blood 120 (12), 2454-2465, 2012
18542012
Somatic mutations of calreticulin in myeloproliferative neoplasms
KR Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi
New England Journal of Medicine 369 (25), 2379-2390, 2013
15552013
Clinical and biological implications of driver mutations in myelodysplastic syndromes
E Papaemmanuil, M Gerstung, L Malcovati, S Tauro, G Gundem, ...
Blood, The Journal of the American Society of Hematology 122 (22), 3616-3627, 2013
11122013
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
L Malcovati, U Germing, A Kuendgen, MG Della Porta, C Pascutto, ...
Journal of clinical oncology 25 (23), 3503-3510, 2007
10832007
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ...
New England Journal of Medicine 365 (15), 1384-1395, 2011
9842011
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making
L Malcovati, MGD Porta, C Pascutto, R Invernizzi, M Boni, E Travaglino, ...
Journal of Clinical Oncology 23 (30), 7594-7603, 2005
9452005
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
New England Journal of Medicine 369 (2), 111-121, 2013
9252013
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research andá…
F Passamonti, F Cervantes, AM Vannucchi, E Morra, E Rumi, A Pereira, ...
Blood, The Journal of the American Society of Hematology 115 (9), 1703-1708, 2010
6752010
Cardiovascular events and intensity of treatment in polycythemia vera
R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ...
N Engl J Med 368, 22-33, 2013
5832013
Mutations and prognosis in primary myelofibrosis
AM Vannucchi, TL Lasho, P Guglielmelli, F Biamonte, A Pardanani, ...
Leukemia 27 (9), 1861-1869, 2013
5232013
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
L Malcovati, E Hellstr÷m-Lindberg, D Bowen, L AdŔs, J Cermak, ...
Blood 122 (17), 2943-2964, 2013
5062013
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
F Passamonti, E Rumi, E Pungolino, L Malabarba, P Bertazzoni, ...
The American journal of medicine 117 (10), 755-761, 2004
4962004
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
E Rumi, D Pietra, V Ferretti, T Klampfl, AS Harutyunyan, JD Milosevic, ...
Blood, The Journal of the American Society of Hematology 123 (10), 1544-1551, 2014
4892014
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
A Tefferi, E Rumi, G Finazzi, H Gisslinger, AM Vannucchi, F Rodeghiero, ...
Leukemia 27 (9), 1874-1881, 2013
4422013
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
L Malcovati, E Papaemmanuil, DT Bowen, J Boultwood, MG Della Porta, ...
Blood, The Journal of the American Society of Hematology 118 (24), 6239-6246, 2011
3992011
Myelodysplastic syndromes—coping with ineffective hematopoiesis
M Cazzola, L Malcovati
N Engl J Med 352 (6), 536-8, 2005
3972005
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q
P Fenaux, A Giagounidis, D Selleslag, O Beyne-Rauzy, G Mufti, ...
Blood, The Journal of the American Society of Hematology 118 (14), 3765-3776, 2011
3902011
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
S Stilgenbauer, A Schnaiter, P Paschka, T Zenz, M Rossi, K D÷hner, ...
Blood, The Journal of the American Society of Hematology 123 (21), 3247-3254, 2014
3762014
The system can't perform the operation now. Try again later.
Articles 1–20